| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Nov 19, 2025 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 41.3 | -3,960 | -2.17% | ✓ | $95.4K |
| Aug 1, 2025 | Aug 4, 2025 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 52.5 | -315 | -0.17% | ✗ | $7K |
| Jun 3, 2025 | Jun 5, 2025 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 42.5 | -5,084 | -2.72% | ✗ | $134.2K |
| Jan 2, 2025 | Jan 6, 2025 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 48.8 | -1,250 | -1.32% | ✓ | $23K |
| Aug 1, 2024 | Aug 2, 2024 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 48.8 | -1,250 | -1.31% | ✓ | $25.3K |
| Jun 28, 2024 | Jul 3, 2024 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 37.5 | -3,312 | -3.35% | ✓ | $106.1K |
| Jun 11, 2024 | Jun 13, 2024 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 95.0 | +49,288 | 99.41% | ✓ | $143.2K |
| Jun 3, 2024 | Jun 5, 2024 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 46.3 | -1,615 | -3.15% | ✗ | $49.9K |
| Jun 6, 2023 | Jun 7, 2023 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 26.3 | -961 | -2.58% | ✗ | $36.9K |
| Aug 3, 2022 | Aug 5, 2022 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 36.3 | -308 | -0.82% | ✗ | $17.2K |
| Jul 5, 2022 | Jul 7, 2022 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 22.5 | -924 | -2.41% | ✗ | $52.8K |
| Jun 6, 2022 | Jun 8, 2022 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 91.3 | +9,538 | 33.40% | ✗ | $22.2K |